This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Amphotericin B and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (102)
Death (44)
Life Threatening Events (14)
Disability (1)
Reports by Reaction Type
Immune Reconstitution Syndrome (14),
Renal Failure Acute (14),
Renal Impairment (10),
Drug Ineffective (8),
Pyrexia (8),
Bronchopulmonary Aspergillosis (8),
Dyspnoea (8),
Liver Injury (7),
Meningitis (7),
Renal Failure (7),
Respiratory Failure (7),
Diarrhoea (7)
Below are a few examples of reports where side effects / adverse reactions may be related to Amphotericin B. For a complete list or a specific selection of reports, please use the links above.
Possible Amphotericin B side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male, weighing 48.0 kg (105.6 pounds)
Reactions: Memory Impairment
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Granisetron
Dosage: 3 mg, per day
Start date: 2012-08-08
End date: 2012-08-11
Sulfamethoxazole and Trimethoprim
Dosage: 2x120mg every sat, sun and mon
Administration route: Oral
Cytarabine
Dosage: 110 mg, per day
Start date: 2012-08-08
End date: 2012-08-11
Furosemide
Dosage: 2x10mg/d
Start date: 2012-08-09
End date: 2012-08-11
Imatinib Mesylate
Dosage: 450 mg, per day
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-13
Granisetron
Dosage: 3 mg, per day
Start date: 2012-08-16
Mercaptopurine
Dosage: 1x87.5mg/d average
Administration route: Oral
Start date: 2012-08-06
Cytarabine
Dosage: 110 mg, per day
Start date: 2012-08-16
Amphotericin B
Dosage: 6x60 mg/d
Administration route: Oral
Start date: 2012-06-24
Pantoprazole
Dosage: 40 mg, per day
Administration route: Oral
Start date: 2012-06-24
End date: 2012-08-15
Possible Amphotericin B side effects in 63 year old male
Reported by a pharmacist from United States on 2012-08-16
Patient: 63 year old male
Reactions: Drug Intolerance, Gastrointestinal Disorder
Drug(s) suspected as cause:
Itraconazole
Administration route: Oral
Indication: Histoplasmosis
Start date: 2006-06-01
End date: 2007-03-01
Amphotericin B
Dosage: for 2 weeks
Indication: Histoplasmosis
Start date: 2006-06-01
Corticosteroids
Indication: Histoplasmosis
Tacrolimus
Indication: Histoplasmosis
Other drugs received by patient: Azathioprine Sodium; Mycophenolate Mofetil; Cyclosporine; Sirolimus
Possible Amphotericin B side effects in 48 year old male
Reported by a physician from United States on 2012-08-16
Patient: 48 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia Cryptococcal, Anaphylactic Reaction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Administration route: Oral
Start date: 2012-01-08
End date: 2012-01-28
Prednisone TAB
Indication: Kidney Transplant Rejection
Cellcept
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-02-14
Cellcept
Administration route: Oral
Prednisone TAB
Start date: 2011-08-18
Sirolimus
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2010-06-25
End date: 2012-01-31
Amphotericin B
Indication: Pneumonia Cryptococcal
Start date: 2012-01-08
End date: 2012-01-28
Cellcept
Administration route: Oral
Start date: 2012-01-31
Other drugs received by patient: Humalog; Amlodipine; Lantus; Aspirin; Moxifloxacin; Pantoprazole; Lantus
Possible Amphotericin B side effects in 4 year old male
Reported by a physician from Brazil on 2012-08-14
Patient: 4 year old male
Reactions: NO Therapeutic Response
Adverse event resulted in: death
Drug(s) suspected as cause:
Amphotericin B
Indication: Fusarium Infection
Voriconazole
Indication: Fusarium Infection
Possible Amphotericin B side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient: 52 year old female
Reactions: Histoplasmosis, Drug Level Below Therapeutic
Drug(s) suspected as cause:
Amphotericin B
Dosage: 13 days
Start date: 2007-12-01
Tacrolimus
Indication: Histoplasmosis
Itraconazole
Dosage: twice a day to three times a day, because of phenytoin
Administration route: Oral
Indication: Histoplasmosis
Start date: 2005-03-01
End date: 2007-01-01
Sirolimus
Indication: Histoplasmosis
Itraconazole
Administration route: Oral
Start date: 2007-12-01
End date: 2009-01-01
Amphotericin B
Dosage: for 16 days
Indication: Histoplasmosis
Start date: 2005-03-01
Other drugs received by patient: Phenytoin
Possible Amphotericin B side effects in 4 year old male
Reported by a physician from Brazil on 2012-08-09
Patient: 4 year old male
Reactions: NO Therapeutic Response
Adverse event resulted in: death
Drug(s) suspected as cause:
Voriconazole
Indication: Fusarium Infection
Amphotericin B
Indication: Fusarium Infection
Possible Amphotericin B side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Morocco on 2012-08-05
Patient: 71 year old male
Reactions: Disseminated Cryptococcosis, General Physical Health Deterioration, Loss of Consciousness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Flucytosine
Indication: Disseminated Cryptococcosis
Amphotericin B
Indication: Disseminated Cryptococcosis
Azathioprine Sodium
Dosage: 100 mg
Indication: Pemphigus
Prednisone TAB
Dosage: 10 mg
Indication: Pemphigus
Possible Amphotericin B side effects in
Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-08-02
Patient:
Reactions: Squamous Cell Carcinoma, NO Therapeutic Response
Drug(s) suspected as cause:
Itraconazole
Dosage: between 200 mg day 1 and 400 mg day 1 depending on the severity of the lesion.
Indication: Chromoblastomycosis
Amphotericin B
Dosage: when necessary
Indication: Chromoblastomycosis
Possible Amphotericin B side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: 57 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Itraconazole
Indication: Fungal Infection
Amphotericin B
Indication: Fungal Infection
Other drugs received by patient: Prednisone; Tacrolimus; Mycophenolate Mofetil
Possible Amphotericin B side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: 67 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Amphotericin B
Dosage: for 3 months
Indication: Fungal Infection
Itraconazole
Indication: Fungal Infection
Amphotericin B-Deoxycholate
Dosage: for 4 days
Indication: Fungal Infection
Other drugs received by patient: Prednisone; Azathioprine; Tacrolimus
Possible Amphotericin B side effects in 33 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: 33 year old male, weighing 93.0 kg (204.6 pounds)
Reactions: Lactobacillus Infection, Blood PH Increased, Tachycardia, Blood PH Decreased, Device Related Infection, Scleral Haemorrhage, Bacterial Sepsis, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Blood Bicarbonate Increased, Acute Respiratory Failure, Renal Failure Acute, Febrile Neutropenia, Haemodialysis, Alopecia, Treatment Failure, Base Excess Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vancomycin
Indication: Product Used FOR Unknown Indication
Daunorubicin HCL
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-04-01
Daunorubicin HCL
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-14
End date: 2012-04-16
Imipenem and Cilastatin
Dosage: 1000 mg, q8 hours intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-05-07
End date: 2012-05-28
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-04-09
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-04-08
End date: 2012-04-08
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-05-20
End date: 2012-05-22
Voriconazole
Dosage: 522 mg, q12 hours, intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-08
End date: 2012-05-08
Penicillin G
Dosage: 24000000 u, q24 hrs intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-05-04
End date: 2012-05-09
Amphotericin B
Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
Indication: Fungal Infection
Start date: 2012-05-06
End date: 2012-05-08
Amphotericin B
Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
Indication: Infection Prophylaxis
Start date: 2012-05-06
End date: 2012-05-08
Aztreonam
Dosage: see image
Indication: Bacterial Infection
Start date: 2012-05-06
End date: 2012-05-07
Aztreonam
Dosage: see image
Indication: Bacterial Infection
Start date: 2012-04-09
End date: 2012-04-10
Cefepime
Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-03-29
End date: 2012-04-10
Cefepime
Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-06-02
End date: 2012-06-05
(Investigational Drug)
Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-17
End date: 2012-04-23
(Investigational Drug)
Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-02
End date: 2012-04-08
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-14
End date: 2012-04-20
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-04-05
Other drugs received by patient: Ondansetron; Seroquel; Percocet; Nystatin; Zyloprim; Acetaminophen; Calcium Carbonate; Lorazepam; Xanax; Allopurinol; Calcium Gluconate; Ibuprofen; Hydroxyzine Pamoate; Celexa
Possible Amphotericin B side effects in 14 year old female
Reported by a physician from Japan on 2012-07-23
Patient: 14 year old female
Reactions: Renal Impairment, Drug Ineffective, Acute Graft Versus Host Disease, Acute Graft Versus Host Disease in Skin
Drug(s) suspected as cause:
Amphotericin B
Prograf
Indication: Unrelated Donor Bone Marrow Transplantation Therapy
Other drugs received by patient: Dopamine HCL
Possible Amphotericin B side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-03
Patient:
Reactions: Fungal Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Itraconazole
Dosage: for a median total duration of 18 months
Indication: Histoplasmosis
Mycophenolate Mofetil
Indication: Blastomycosis
Cyclosporine
Indication: Blastomycosis
Corticosteroids
Indication: Blastomycosis
Cyclosporine
Indication: Histoplasmosis
Tacrolimus
Indication: Histoplasmosis
Amphotericin B
Indication: Blastomycosis
Amphotericin B
Indication: Histoplasmosis
Tacrolimus
Indication: Blastomycosis
Mycophenolate Mofetil
Indication: Histoplasmosis
Corticosteroids
Indication: Histoplasmosis
Sirolimus
Indication: Blastomycosis
Azathioprine
Indication: Blastomycosis
Itraconazole
Dosage: for a median total duration of 18 months
Indication: Blastomycosis
Sirolimus
Indication: Histoplasmosis
Azathioprine
Indication: Histoplasmosis
Possible Amphotericin B side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient:
Reactions: Drug Level Below Therapeutic, Histoplasmosis
Drug(s) suspected as cause:
Mycophenolate Mofetil
Indication: Histoplasmosis
Cyclosporine
Indication: Histoplasmosis
Tacrolimus
Indication: Histoplasmosis
Itraconazole
Administration route: Oral
Indication: Histoplasmosis
Azathioprine
Indication: Histoplasmosis
Amphotericin B
Indication: Histoplasmosis
Corticosteroids
Indication: Histoplasmosis
Sirolimus
Indication: Histoplasmosis
Possible Amphotericin B side effects in male
Reported by a physician from Greece on 2012-07-02
Patient: male, weighing 166.7 kg (366.6 pounds)
Reactions: Anaphylactic Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ceftazidime
Dosage: iv
Indication: Pyrexia
Start date: 2011-12-02
End date: 2011-12-20
Teicoplanin (NO Pref. Name)
Dosage: iv
Indication: Pyrexia
Start date: 2011-12-02
End date: 2011-12-18
Amphotericin B
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-08
End date: 2011-12-08
Cyclosporine
Dosage: po
Administration route: Oral
Indication: Aplastic Anaemia
Start date: 2011-11-11
Possible Amphotericin B side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient:
Reactions: Blastomycosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Sirolimus
Indication: Blastomycosis
Azathioprine
Indication: Blastomycosis
Itraconazole
Indication: Blastomycosis
Mycophenolate Mofetil
Indication: Blastomycosis
Amphotericin B
Indication: Blastomycosis
Tacrolimus
Indication: Blastomycosis
Corticosteroids
Indication: Blastomycosis
Cyclosporine
Indication: Blastomycosis
Possible Amphotericin B side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient:
Reactions: Histoplasmosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Amphotericin B
Indication: Histoplasmosis
Cyclosporine
Indication: Histoplasmosis
Sirolimus
Indication: Histoplasmosis
Azathioprine
Indication: Histoplasmosis
Tacrolimus
Indication: Histoplasmosis
Mycophenolate Mofetil
Indication: Histoplasmosis
Itraconazole
Dosage: once or twice daily for a median duration of 8 months (range 1-13)
Indication: Histoplasmosis
Corticosteroids
Indication: Histoplasmosis
Possible Amphotericin B side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient:
Reactions: Gastrointestinal Disorder, Drug Intolerance
Drug(s) suspected as cause:
Azathioprine
Indication: Histoplasmosis
Amphotericin B
Indication: Histoplasmosis
Cyclosporine
Indication: Histoplasmosis
Mycophenolate Mofetil
Indication: Histoplasmosis
Sirolimus
Indication: Histoplasmosis
Itraconazole
Administration route: Oral
Indication: Histoplasmosis
Tacrolimus
Indication: Histoplasmosis
Corticosteroids
Indication: Histoplasmosis
Possible Amphotericin B side effects in 55 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-13
Patient: 55 year old female
Reactions: Liver Injury, Zygomycosis, Pneumothorax, Pleural Effusion, Febrile Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Amphotericin B
Indication: Antifungal Prophylaxis
Caspofungin Acetate
Indication: Zygomycosis
Amphotericin B
Indication: Zygomycosis
Anti-Thymocyte Globulin NOS
Indication: Prophylaxis Against Graft Versus Host Disease
Levofloxacin
Indication: Antibiotic Prophylaxis
Voriconazole
Indication: Antifungal Prophylaxis
Cyclosporine
Indication: Prophylaxis Against Graft Versus Host Disease
Defarasirox
Indication: Zygomycosis
Fluconazole
Indication: Antifungal Prophylaxis
Busulfan
Indication: Stem Cell Transplant
Methotrexate
Indication: Prophylaxis Against Graft Versus Host Disease
Cyclophosphamide
Indication: Stem Cell Transplant
Piperacillin / Tazobactam
Indication: Febrile Neutropenia
Possible Amphotericin B side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-12
Patient:
Reactions: Renal Failure, Medication Error, Anaemia, Electrolyte Imbalance, Drug Dispensing Error
Drug(s) suspected as cause:
Amphotericin B
Amphotericin B
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-11
Patient: 43 year old male
Reactions: Liver Injury, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Device Related Infection, Death, Renal Failure, Sepsis Syndrome, Renal Impairment, Cardio-Respiratory Arrest, Cardiac Failure, Respiratory Failure, Hallucination, Visual, Neutropenia, Mycobacterium Fortuitum Infection, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ciprofloxacin HCL
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Clarithromycin
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Oseltamivir
Dosage: 75 mg, 2x/day
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Immunosuppression
Amphotericin B
Indication: Aspergillosis
Prednisolone
Dosage: 60 mg, unk
Indication: Immunosuppression
Ciprofloxacin HCL
Dosage: 60 mg
Voriconazole
Dosage: unk
Indication: Aspergillosis
Teicoplanin
Dosage: 400 mg, 1x/day
Indication: Product Used FOR Unknown Indication
Meropenem
Dosage: 1 g, 2x/day
Indication: Product Used FOR Unknown Indication
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) on 2012-06-08
Patient: 43 year old male
Reactions: Liver Injury, Bronchopulmonary Aspergillosis, Neutropenic Sepsis, Cholestasis, H1n1 Influenza, Haemodialysis, Cardio-Respiratory Arrest, Hallucination, Visual, Cardiac Failure, Mycobacterium Fortuitum Infection, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ciprofloxacin
Dosage: 1000 mg (500 mg, 2 in 1 d),
Indication: Mycobacterium Fortuitum Infection
Clarithromycin
Dosage: 1000 mg (500 mg, 2 in 1 d),
Indication: Mycobacterium Fortuitum Infection
Teicoplanin (Teicoplanin)
Dosage: 400 mg (400 mg, 1 in 1 d), parenteral
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg (100 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Immunosuppression
Oseltamivir Phosphate
Dosage: 150 mg (75 mg, 2 in 1 d), parenteral
Indication: Product Used FOR Unknown Indication
Prednisolone
Dosage: 60 mg,
Indication: Immunosuppression
Voriconazole
Indication: Aspergillosis
Meropenem
Dosage: 2 gm (1 gm, 2 in 1 d), parenteral
Indication: Product Used FOR Unknown Indication
Amphotericin B
Indication: Aspergillosis
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-05
Patient: 43 year old male
Reactions: Liver Injury, Right Ventricular Failure, Dyspnoea, Haemoptysis, Cholestasis, Cardio-Respiratory Arrest, Sepsis Syndrome, Respiratory Failure, Aspergillosis, Neutropenia, Mycobacterium Fortuitum Infection, Renal Failure Acute, Influenza A Virus Test Positive
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisolone
Dosage: 60 mg, daily
Administration route: Oral
Indication: Renal Vasculitis
Ciprofloxacin HCL
Dosage: 500 mg, bid
Indication: Mycobacterium Fortuitum Infection
Meropenem
Dosage: 1 g, bid
Indication: Sepsis Syndrome
Amikacin
Indication: Mycobacterium Fortuitum Infection
Amphotericin B
Indication: Aspergillosis
Prednisolone
Indication: Pulmonary Vasculitis
Voriconazole
Dosage: unk
Indication: Aspergillosis
Cyclophosphamide
Indication: Pulmonary Vasculitis
Oseltamivir
Dosage: 75 mg, bid
Indication: Sepsis Syndrome
Clarithromycin
Dosage: 500 mg, bid
Indication: Mycobacterium Fortuitum Infection
Teicoplanin
Dosage: 400 mg, daily
Indication: Sepsis Syndrome
Cyclophosphamide
Dosage: 100 mg, daily
Administration route: Oral
Indication: Renal Vasculitis
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) on 2012-05-30
Patient: 43 year old male
Reactions: Bronchopulmonary Aspergillosis, Liver Injury, Haemoptysis, Neutropenic Sepsis, Device Related Infection, H1n1 Influenza, Renal Failure, Cardio-Respiratory Arrest, Hallucination, Visual, Cardiac Failure, Respiratory Failure, Mycobacterium Fortuitum Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Teicoplanin (Teicoplanin)
Indication: Product Used FOR Unknown Indication
Voriconazole
Indication: Product Used FOR Unknown Indication
Clarithromycin
Dosage: 1000 mg (500 mg, 2 in 1 d)
Indication: Mycobacterium Fortuitum Infection
Prednisolone
Dosage: 60 mg
Indication: Immunosuppression
Oseltamivir Phosphate
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg (100 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Immunosuppression
Amphotericin B
Indication: Aspergillosis
Ciprofloxacin
Dosage: 1000 mg (500 mg, 2 in 1 d)
Indication: Mycobacterium Fortuitum Infection
Meropenem
Indication: Product Used FOR Unknown Indication
Possible Amphotericin B side effects in 47 year old female
Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-05-30
Patient: 47 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: Hepatomegaly, Respiratory Disorder, Respiratory Tract Haemorrhage, Candidiasis, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Tretinoin
Dosage: 40 mg/m2/day continuously
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Metamizole
Dosage: 500 mg
Administration route: Oral
Indication: Febrile Neutropenia
Fluconazole
Dosage: 200 mg/day
Administration route: Oral
Indication: Candidiasis
Mitoxantrone
Dosage: 20 mg/m2/day
Indication: Acute Promyelocytic Leukaemia
Amphotericin B
Dosage: 30 mg/day, 6 hours of infusion
Indication: Candidiasis
Cytarabine
Dosage: 370 mg/m2/day
Indication: Acute Promyelocytic Leukaemia
Cefepime
Dosage: 2 g, every eight hours
Indication: Febrile Neutropenia
Other drugs received by patient: Meropenem; Methotrexate; Tretinoin
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30
Patient: 43 year old male
Reactions: Liver Injury, Device Related Infection, Death, Cardio-Respiratory Arrest, Mycobacterium Fortuitum Infection, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Sepsis Syndrome, Renal Failure, Renal Impairment, Cardiac Failure, Hallucination, Visual, Respiratory Failure, Neutropenia, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ciprofloxacin HCL
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Prednisolone
Dosage: 60 mg, unk
Indication: Immunosuppression
Oseltamivir
Indication: Product Used FOR Unknown Indication
Teicoplanin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Immunosuppression
Clarithromycin
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Voriconazole
Dosage: unk
Indication: Aspergillosis
Meropenem
Indication: Product Used FOR Unknown Indication
Amphotericin B
Indication: Aspergillosis
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-28
Patient: 43 year old male
Reactions: Bronchopulmonary Aspergillosis, Liver Injury, Renal Failure, Endocarditis Bacterial, Cardiac Failure, Neutropenic Sepsis, H1n1 Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Meropenem
Amikacin
Cyclophosphamide
Administration route: Oral
Indication: Vasculitis
Clarithromycin
Indication: Infection
Amphotericin B
Voriconazole
Prednisolone
Administration route: Oral
Indication: Vasculitis
Ciprofloxacin
Indication: Infection
Teicoplanin
Oseltamivir Phosphate
Possible Amphotericin B side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-05-22
Patient: 29 year old female
Reactions: Drug Ineffective, Candida Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Micafungin
Dosage: 100 mg, uid/qd
Indication: Lung Transplant
Amphotericin B
Dosage: 250 mg, uid/qd
Indication: Lung Transplant
Other drugs received by patient: Basiliximab; Tacrolimus; Mycophenolate Mofetil; Corticosteroid NOS
Possible Amphotericin B side effects in male
Reported by a physician from Korea, Republic of on 2012-05-10
Patient: male, weighing 55.0 kg (121.0 pounds)
Reactions: Pneumonia Fungal, Fatigue, Aspergillus Test Positive, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Pertuzumab
Dosage: date of most recent dose prior to sae: 18/jan/2012
Indication: Gastric Cancer
Start date: 2011-12-21
Amphotericin B
Indication: Product Used FOR Unknown Indication
Herceptin
Dosage: date of most recent dose prior to sae: 18/jan/2012
Indication: Gastric Cancer
Start date: 2011-12-21
Cisplatin
Dosage: date of most recent dose prior to sae: 18/jan/2012
Indication: Gastric Cancer
Start date: 2011-12-21
Xeloda
Dosage: date of most recent dose prior to sae: 31/jan/2012
Administration route: Oral
Indication: Gastric Cancer
Start date: 2011-12-21
Voriconazole
Indication: Product Used FOR Unknown Indication
Possible Amphotericin B side effects in 26 year old male
Reported by a physician from United States on 2012-05-01
Patient: 26 year old male
Reactions: Histoplasmosis, Small Intestinal Obstruction, Small Intestinal Perforation
Drug(s) suspected as cause:
Amphotericin B
Antiretrovirals (Nos)
Indication: Product Used FOR Unknown Indication
Amphotericin B
Indication: Histoplasmosis
Itraconazole
Administration route: Oral
Indication: Histoplasmosis
|
